C12Y 304/22056
Caspase-3
Official title: Caspase-3 (3.4.22.56)
C12Y304/22056 (Caspase-3) appears on 13 US grants and 29 published applications in this corpus.
Search patents in C12Y- Granted patents
- 13
- Published applications
- 29
- Assignees
- 24
- Inventors
- 73
- Latest grant
- 12 Mar 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 2 |
| 2004 | 0 | 0 |
| 2005 | 1 | 1 |
| 2006 | 0 | 1 |
| 2007 | 0 | 1 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 1 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 1 |
| 2014 | 1 | 2 |
| 2015 | 2 | 2 |
| 2016 | 0 | 0 |
| 2017 | 0 | 2 |
| 2018 | 1 | 0 |
| 2019 | 1 | 3 |
| 2020 | 0 | 1 |
| 2021 | 1 | 1 |
| 2022 | 0 | 2 |
| 2023 | 2 | 1 |
| 2024 | 2 | 3 |
| 2025 | 0 | 4 |
By publication year.
Recent patents
- Method of screening inhibitor of caspase activity by lipopolysaccharide12 Mar 2024US 11,926,860 B2Korea Institute of Science and Technology
- Compositions and methods for preparing capped mRNA13 Feb 2024US 11,898,186 B1Genscript USA Inc.
- Process for determining enzyme activity in a cell by activity-based reporter gene technology (ABRGT)5 Dec 2023US 11,834,698 B2Indian Institute of Science Education and Research
- Fusogenic lipid nanoparticles for target cell-specific production of a therapeutic protein14 Mar 2023US 11,603,543 B2Oisin Biotechnologies, Inc.
- Nano/micromotors for active and dynamic intracellular payload delivery18 May 2021US 11,007,281 B2The Regents of the University of Californa
- Fusogenic lipid nanoparticles and methods for the manufacture and use thereof for the target cell-specific production of a therapeutic protein and for the treatment of a disease13 Nov 2025US 2025/0346925 A1Oisin Biotechnologies, Inc.
- Improved cell lines and methods for the production of adeno-associated vectors22 May 2025US 2025/0163459 A1Cevec Pharmaceuticals GmbH
- Synpoptosis circuits for programmable cell death control15 May 2025US 2025/0152743 A1
- Compositions and methods for preparing capped mrna27 Mar 2025US 2025/0101480 A1Genscript USA Inc.
- A photoresponsive delivery system based on a modified pamam and methods thereof22 Aug 2024US 2024/0277867 A1The University of Hong Kong
Most cited
By later US patents
- Antisense modulation of caspase 3 expression153US 6,303,374 B1Isis Pharmaceuticals, Inc. · 2001
- Nano/micromotors for active and dynamic intracellular payload delivery2US 11,007,281 B2The Regents of the University of Californa · 2021
- Near-infrared light-activated proteins1US 10,041,057 B2University of Wyoming · 2018
- Fusogenic lipid nanoparticles for target cell-specific production of a therapeutic protein1US 11,603,543 B2Oisin Biotechnologies, Inc. · 2023
- Function of autophagy genes in cell death1US 7,838,645 B2National Institutes of Health · 2010